850 sedative injections seized from a medical shop at Burma Camp in Visakhapatnam, five arrested

The City Task Force (CTF) officials, in coordination with the Kancharapalem police, raided a medical shop at Burma Camp and seized around 850 Pentazocine Lactate Injections which are generally used as psychotropic substances here on Thursday night.

The arrested were identified as G. Kalyan Kumar (40), who runs the medical shop, Ch. Prasad (27), P. Ram Prasad (26), V. Bala Appala Swamy (36) and P. Santosh Kumar (23), all from Kancharapalem.

Police Commissioner C.M. Trivikrama Varma said that it was found that Kalyan Kumar had been selling the sedative injections for th the last one month. He used to purchase the injections from a person named Harish, who is a dealer of a renowned online shopping app from Gujarat. It was also found that the accused used to procure one injection for about ₹11 and would sell for ₹250. He said that the other accused in the case used to consume and sell the same to other persons.

He said that the accused had procured 1,000 sedative injections in which 150 injections were already sold.

Mr. Trivikrama Varma said that the Pentazocine Lactate injection are used as a painkiller at the time of surgical operations and it can only be sold by the hospitals or medical shops, which have the licence to sell such drugs. The injection should be administered by a medical surgeon and the usage should be recorded.

“The Visakhapatnam police would write to the Gujarat government about the case,” he said, adding that “While these sedative injections cannot be sold without prescription, some dealers are selling it online shockingly.”

Related Posts

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Gujarat based Senores Pharmaceuticals Ltd on Monday, December 15, announced that it has entered into a share purchase agreement to acquire a 100% equity stake in Apnar Pharma Private Ltd.…

Aytu BioPharma launches depression drug EXXUA in U.S. market

DENVER-  Aytu BioPharma, Inc. (NASDAQ:AYTU) announced Monday the commercial availability of EXXUA in the United States for the treatment of major depressive disorder (MDD). The small-cap biotech, with a market…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

ITS in AMTZ, 70 Countries participated for Future of Health Technology

ITS in AMTZ, 70 Countries participated for Future of Health Technology

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session